Literature DB >> 26146770

Preparation and evaluation of floating tablets of pregabalin.

Navjot Kanwar1, Rakesh Kumar1, Amita Sarwal1, V R Sinha1.   

Abstract

Floating tablets of pregabalin were prepared using different concentrations of the gums (xanthan gum and guar gum), Carbopol 974P NF and HPMC K100. Optimized formulations were studied for physical tests, floating time, swelling behavior, in vitro release studies and stability studies. In vitro drug release was higher for tablet batches containing guar and xanthan gum as compared to the batches containing Carbopol 974P NF. Tablet batches were subjected to stability studies and evaluated by different parameters (drug release, drug content, FTIR and DSC studies). The optimized tablet batch was selected for in vivo pharmacodynamic studies (PTZ induced seizures). The results obtained showed that the onset of jerks and clonus were delayed and extensor phase was abolished with time in treated groups. A significant difference (p > 0.05) was observed in control and treated group behavior indicating an excellent activity of the formulation for a longer period (>12 h).

Entities:  

Keywords:  Floating tablets; guar gum; pregabalin; seizure; xanthan gum

Mesh:

Substances:

Year:  2015        PMID: 26146770     DOI: 10.3109/03639045.2015.1062895

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  3 in total

Review 1.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

2.  Quetiapine Fumarate Extended-release Tablet Formulation Design Using Artificial Neural Networks.

Authors:  Esher Özçelik; Burcu Mesut; Buket Aksu; Yıldız Özsoy
Journal:  Turk J Pharm Sci       Date:  2017-11-20

3.  Development of a Novel Controlled-Release Tablet of Pregabalin: Formulation Variation and Pharmacokinetics in Dogs and Humans.

Authors:  Kyung Hun Kim; Seo Hyun Lim; Cho Rok Shim; Junsung Park; Woo Heon Song; Min Chang Kwon; Jong Hyuk Lee; Jun Sang Park; Han-Gon Choi
Journal:  Drug Des Devel Ther       Date:  2020-01-30       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.